Symbol Name ID |
Pkd2l2
polycystic kidney disease 2-like 2 MGI:1858231 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Pkd2l2tm1b(EUCOMM)Wtsi/Pkd2l2tm1b(EUCOMM)Wtsi C57BL/6N-Pkd2l2tm1b(EUCOMM)Wtsi/H |
decreased bone mineral density | J:211773 |
decreased fasting circulating glucose level | J:211773 | |
increased blood urea nitrogen level | J:211773 | |
increased circulating creatinine level | J:211773 | |
increased circulating fructosamine level | J:211773 | |
increased circulating potassium level | J:211773 | |
Pkd2l2tm1Dgen/Pkd2l2tm1Dgen involves: 129P2/OlaHsd * C57BL/6 |
increased exploration in new environment | J:101679 |
increased locomotor activity | J:101679 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|